Rigel Pharmaceuticals Inc financial data

Symbol
RIGL on Nasdaq
Industry
Pharmaceutical Preparations
Location
611 Gateway Boulevard, Suite 900, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 163 % -24%
Quick Ratio 11.3 % -40.3%
Debt-to-equity -499 %
Return On Equity 46.6 % -73.5%
Return On Assets -11.7 % +62.1%
Operating Margin -6.92 % +74.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares -89.9%
Common Stock, Shares, Outstanding 175M shares +0.82%
Entity Public Float 223M USD +15%
Common Stock, Value, Issued 17K USD -90.3%
Weighted Average Number of Shares Outstanding, Basic 17.5M shares +1.11%
Weighted Average Number of Shares Outstanding, Diluted 17.5M shares +1.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 130M USD +2.89%
Costs and Expenses 139M USD -13.4%
Operating Income (Loss) -9.02M USD +73.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -58.6M USD -238%
Income Tax Expense (Benefit) -60K USD
Net Income (Loss) Attributable to Parent -14.2M USD +62.3%
Earnings Per Share, Basic 0.21 USD/shares +84.2%
Earnings Per Share, Diluted 0.21 USD/shares +84.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.1M USD -26.1%
Cash, Cash Equivalents, and Short-term Investments 49.1M USD -23.7%
Accounts Receivable, after Allowance for Credit Loss, Current 28.9M USD +38.8%
Inventory, Net 8.06M USD -25.3%
Assets, Current 94.7M USD -6.15%
Property, Plant and Equipment, Net 115K USD -46.5%
Operating Lease, Right-of-Use Asset 560K USD -43.8%
Other Assets, Noncurrent 4.74M USD +775%
Assets 128M USD +9.67%
Accounts Payable, Current 6.13M USD +17%
Employee-related Liabilities, Current 6.37M USD -5.43%
Contract with Customer, Liability, Current 1.36M USD 0%
Liabilities, Current 58.6M USD +33.2%
Operating Lease, Liability, Noncurrent 100K USD -87.5%
Other Liabilities, Noncurrent 40M USD -2.44%
Liabilities 158M USD +9.03%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9K USD +64%
Retained Earnings (Accumulated Deficit) -1.42B USD -1.02%
Stockholders' Equity Attributable to Parent -29.9M USD -6.4%
Liabilities and Equity 128M USD +9.67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.01M USD -23%
Net Cash Provided by (Used in) Financing Activities -2.51M USD -113%
Net Cash Provided by (Used in) Investing Activities 313K USD -59.7%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 175M shares +0.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 36.1M USD -26.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.68M USD +66.6%
Deferred Tax Assets, Valuation Allowance 339M USD +0.29%
Deferred Tax Assets, Gross 339M USD +0.29%
Operating Lease, Liability 8.3M USD -51.7%
Payments to Acquire Property, Plant, and Equipment 224K USD +215%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.2M USD +61.9%
Lessee, Operating Lease, Liability, to be Paid 672K USD -52%
Property, Plant and Equipment, Gross 1.87M USD -84%
Operating Lease, Liability, Current 639K USD +37.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 301K USD -59.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 301K USD -59.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 301K USD
Deferred Tax Assets, Operating Loss Carryforwards 230M USD -0.18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.67M USD -8%
Operating Lease, Payments 728K USD -88.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 600K USD +100%
Depreciation, Depletion and Amortization 400K USD +12%
Share-based Payment Arrangement, Expense 11.5M USD -1.53%
Interest Expense 7.71M USD +54.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%